TIDMEFIM
RNS Number : 5220U
IVZ GS Eqty Fctr EM UCITS $
28 March 2023
Click on, or paste the following link into your web browser, to
view the associated PDF document.
http://www.rns-pdf.londonstockexchange.com/rns/5220U_1-2023-3-28.pdf
Invesco Markets plc
Ground Floor, 2 Cumberland
Place, Fenian Street, Dublin
2, Ireland
Telephone +353 1 439 8000
www.invesco.com
IMPORTANT: This document is important and requires your
immediate attention. If you are in any doubt as to the action you
should take you should seek advice from your stockbroker, bank
manager, solicitor, accountant or other independent financial
adviser.
If you have sold or transferred all of your shares in the Fund
(as defined below), please pass this document at once to the
purchaser or transferee or to the stockbroker, bank or other agent
through whom the sale or transfer was effected for transmission to
the purchaser or transferee as soon as possible.
Capitalised terms used herein shall bear the same meaning as
capitalised terms used in the Prospectus dated 30 November 2022.
Copies of the Prospectus are available upon request during normal
business hours from the registered office of the Company or from
the local representative of the Company in each jurisdiction in
which the sub-funds of the Company are registered for public
distribution.
In accordance with the current policy of the Central Bank, this
document has not been reviewed by the Central Bank.
28 March 2023
Invesco Markets plc (the "Company")
Fund ISIN
Invesco Goldman Sachs Equity Factor Index Emerging Markets UCITS ETF IE00BD5KGK77
-------------
(the "Fund")
Dear Shareholder,
We are writing to you as a Shareholder in the Fund to inform you
that the board of directors (the "Board") has, with regret,
determined that, pursuant to Clause 10 Appendix II of the
Memorandum & Articles of Association of the Company (the
"M&A"), it is in the best interests of the Shareholders to
terminate the Fund with effect from 10 May 2023 (the "Termination
Date").
The decision of the Board to terminate the Fund is based on the
advice of the promoter and investment manager that the continued
existence and operation of the Fund is not economically viable.
Therefore, in accordance with the above provisions of the
M&A and the Prospectus, the Board hereby gives notice of our
intention:
i) cancel the listing of the Fund and the right of the Fund to
be traded on any relevant stock exchanges with effect from close of
business on 28 April 2023;
ii) terminate the Fund with effect from 3 May 2023; and
iii) to proceed with the compulsory repurchase of all outstanding shares of the Fund.
PROPOSED TIMETABLE
Key Dates Event
28 April 2023 (Friday) Final Exchange Trading Date
--------------------------------
2 May 2023 (Tuesday) Final Dealing Date (Voluntary
Create/Redeem)
--------------------------------
3 May 2023 (Wednesday) Mandatory Redemption Trade Date
(and Termination Date)
--------------------------------
10 May 2023 (Wednesday) Redemption Settlement Date
--------------------------------
ADDITIONAL INFORMATION
Requests for repurchase or subscription for Shares in the Fund
may be made in the usual manner in accordance with the Prospectus
and supplements for the Fund (the "Supplement") until 2 May
2023.
The following terms and conditions of such compulsory repurchase
shall apply as of the Termination Date:
1. the Fund shall be terminated and the repurchase price for
each Class of Shares of the Fund will be determined by reference to
the Net Asset Value of the respective Class of Shares of the Fund
as of the Termination Date. The costs in relation to the
termination will be borne by the Manager;
2. no repurchase charge will be applied;
3. the repurchase proceeds will be paid in the relevant Share Class currency;
4. the payment of the repurchase proceeds resulting from the
compulsory repurchase will take place on or around 10 May 2023;
and
5. following the payment of the repurchase proceeds in respect
of the Fund, application will be made to the Central Bank of
Ireland for the withdrawal of approval of the Fund.
Shareholders who subscribe or repurchase Shares in the Fund on
the primary market are entitled to repurchase their Shares in the
Fund in accordance with the Prospectus. Please note that the
Company does not charge any repurchase fee for the sale of Shares
in the secondary market. Orders to sell Shares through a stock
exchange can be placed via an authorised intermediary or
stockbroker. However, Shareholders should note that orders in the
secondary market may incur costs over which the Company has no
control and to which the above disapplication of the repurchase
charge does not apply.
Shareholders may obtain the Prospectus, a copy of the
Supplements, the key investor information and key information
documents, the latest annual and semi-annual reports and copies of
the M&A free of charge from the registered office of the
Manager or the local representatives in the countries where the
Company is registered and in Switzerland at BNP Paribas Securities
Services, Paris, succursale de Zurich, Selnaustrasse 16, 8002
Zurich which is the Swiss representative and paying agent, as well
as from the German information agent Marcard, Stein & Co AG,
Ballindamm 36, 20095 Hamburg, Germany and where applicable on the
website of the Company - www.etf.invesco.com . Shareholders should
consult their own professional advisers as to the specific tax
implications of the termination under the laws of the countries of
their nationality, residence, domicile or incorporation.
If you have any queries arising from this notice, please call
Invesco on +353 1 439 8000 or contact us at invest@invesco.com
.
Yours sincerely
_________________
For and on behalf of
Invesco Markets plc
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
STREASDPALPDEFA
(END) Dow Jones Newswires
March 28, 2023 11:56 ET (15:56 GMT)
Ivz Gs Efi Em (LSE:EFIM)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
Ivz Gs Efi Em (LSE:EFIM)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024
